Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer
NCT05201729
·
clinicaltrials.gov ↗
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Ductal Adenocarcinoma, PDAC
Sponsor
Ruijin Hospital